Guidance

Hib/MenC: patient group direction (PGD) template

PGD template to support the national Haemophilus influenzae type b and meningococcal C conjugate vaccination programme.

From:
UK Health Security Agency
Published
4 February 2016
Last updated
30 June 2022 — See all updates

Applies to England

Documents

Hib/MenC: patient group direction (PGD) template

Ref: UKHSA gateway number GOV-12448

MS Word Document, 122 KB

View online

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of Haemophilus influenzae type b (Hib) and meningococcal C conjugate vaccine to individuals from their first birthday to under 10 years of age in accordance with the national immunisation programme; and to individuals of any age for the prevention of secondary cases of meningococcal group C (MenC) disease in accordance with the Guidance for the public health management of meningococcal disease in the UK.

The Hib/MenC PGD version 05.00 is valid from 31 July 2022 to 1 August 2024.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 4 February 2016
Last updated 30 June 2022 + show all updates

  1. Added version 5.

  2. Added V04.00: routine review.

  3. Updated template to align with new guidance for the public health management of Meningococcal disease in the UK.

  4. Updated to reflect removal of monovalent MenC from routine programme.

  5. First published.

Related content